Regulus Therapeutics Inc.
RGLS
Price:
$2.76
Market Cap:
$182.83M
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headq...[Read more]
Industry
Biotechnology
IPO Date
2012-10-09
Stock Exchange
NASDAQ
Ticker
RGLS
PE Ratio
[-3.37]
ROE
[-50.26%]
Current Ratio
[10.98]
Dividend Yield
[0%]
Enterprise Value
[144.58M]
Dividend History
The ROE as of April 2025 (TTM) for Regulus Therapeutics Inc. (RGLS) is -50.26%
According to Regulus Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -50.26%. This represents a change of 286.19% compared to the average of -13.01% of the last 4 quarters.
Regulus Therapeutics Inc. (RGLS) Historical ROE (quarterly & annually)
How has RGLS ROE performed in the past?
The mean historical ROE of Regulus Therapeutics Inc. over the last ten years is -5.26%. The current -50.26% ROE has changed 854.64% with respect to the historical average. Over the past ten years (40 quarters), RGLS's ROE was at its highest in in the September 2019 quarter at 3.79%. The ROE was at its lowest in in the September 2018 quarter at -651.01%.
Average
-5.26%
Median
-72.87%
Minimum
-204.18%
Maximum
832.06%
Regulus Therapeutics Inc. (RGLS) ROE by Quarter and Year
Discovering the peaks and valleys of Regulus Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 224.82%
Maximum Annual ROE = 832.06%
Minimum Annual Increase = -507.51%
Minimum Annual ROE = -204.18%
| Year | ROE | Change |
|---|---|---|
| 2024 | -60.67% | -57.20% |
| 2023 | -141.77% | 66.64% |
| 2022 | -85.08% | 68.14% |
| 2021 | -50.60% | -13.72% |
| 2020 | -58.65% | -36.87% |
| 2019 | -92.89% | -111.16% |
| 2018 | 832.06% | -507.51% |
| 2017 | -204.18% | 39.91% |
| 2016 | -145.94% | 224.82% |
| 2015 | -44.93% | 4.65% |
Regulus Therapeutics Inc. (RGLS) Average ROE
How has RGLS ROE performed in the past?
The current ROE of Regulus Therapeutics Inc. (RGLS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-95.84%
5-year avg
-79.35%
10-year avg
-5.26%
Regulus Therapeutics Inc. (RGLS) ROE vs. Peers
How is RGLS’s ROE compared to its peers?
Regulus Therapeutics Inc.’s ROE is greater than Infinity Pharmaceuticals, Inc. (-3433.02%), greater than Tenax Therapeutics, Inc. (-33.44%), greater than Verastem, Inc. (-763.98%), greater than Pulmatrix, Inc. (-73.26%), greater than Cellectar Biosciences, Inc. (-232.45%),
| Company | ROE | Market cap |
|---|---|---|
| -3433.02% | $726.09K | |
| -33.44% | $24.06M | |
| -763.98% | $386.18M | |
| -73.26% | $24.51M | |
| -232.45% | $14.28M |
Build a custom stock screener for Regulus Therapeutics Inc. (RGLS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regulus Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Regulus Therapeutics Inc. (RGLS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Regulus Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Regulus Therapeutics Inc.'s ROE?
How is the ROE calculated for Regulus Therapeutics Inc. (RGLS)?
What is the highest ROE for Regulus Therapeutics Inc. (RGLS)?
What is the 3-year average ROE for Regulus Therapeutics Inc. (RGLS)?
What is the 5-year average ROE for Regulus Therapeutics Inc. (RGLS)?
How does the current ROE for Regulus Therapeutics Inc. (RGLS) compare to its historical average?